- All
- Clinical Research
- COVID-19
Schlesinger Group in Spain collaborated with Open Evidence and researchers of various universities, to better understand the effects of Covid-19 and lockdown on populations in Italy, Spain, and United Kingdom.
Schlesinger Group partnered with Northwestern University Feinberg School of Medicine to facilitate a research study to determine how 5 to 12 month old infants would tolerate a nutritional supplement that introduced a proprietary blend of proteins from common allergenic foods into their diet. Participants kept an online diary and completed an online questionnaire at the end of both 28-day usage periods.
